Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Omalizumab in the Treatment of Peanut Allergy

This study has been completed.
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Robert A. Wood, Johns Hopkins University Identifier:
First received: July 29, 2009
Last updated: March 28, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)